Digital Marketing · Service
Pharmaceutical marketing, B2B only
Trade audiences, inside advertising restrictions that vary by market.
At a glance
What it is
“Medical review belongs in the production schedule, not at the end of it.”
A principal, Kaelo Digital Marketing
What’s included
Four areas of scopeTrade and professional channels
Professional networks, endemic medical publishers and trade press permit targeting that the consumer platforms restrict, with their own compliance requirements attached.
Restriction mapping by market
What may be said, to whom, in which market, differs substantially. A campaign compliant in one jurisdiction is not automatically compliant next door.
Approval workflow built in
Medical, legal and regulatory review is part of the production schedule rather than a checkpoint at the end. Treating it as the latter is why pharma campaigns run late.
Corporate and distribution communications
Much of what pharma actually needs is supply, distribution and corporate communication rather than product promotion — and that carries a lighter compliance burden.
How the work runs
Scope and restriction map
Markets, audiences and what is permissible in each.
Review path
MLR built into the schedule from the start.
Trade channels
Where the professional audience actually is.
When to come to us
- 01 You are communicating to trade, professional or procurement audiences.
- 02 You need corporate or distribution communications rather than product promotion.
- 03 You have a review function we can build the schedule around.
What we do not do
- Direct-to-consumer prescription promotion. It is prohibited in our markets and we will decline the brief.
- Any clinical, efficacy or safety claim — those come from your medical function.
- Running creative that has not completed your own review process.
Common questions
